Author: Ershad Moradi

DrugApproval

Pharma Regulatory Consulting Firms 2026: Unlock Your Drug Approval Success

Pharma regulatory consulting firms provide critical expertise that accelerates drug approvals and ensures global compliance. By navigating complex regulations like FDA, EMA, and ICH, these firms reduce risks and optimize submission quality. This blog explores the consulting role, benefits, and key regulations, encouraging knowledge sharing to enhance industry success.

Read More »
QMS in Pharmaceutical Manufacturing

QMS in Pharmaceutical Manufacturing 2026: Unlock Quality & Compliance Success

A robust Quality Management System (QMS) forms the backbone of pharmaceutical manufacturing. It ensures adherence to GMP and global standards, mitigates risks, controls processes, and drives continuous improvement. By maintaining accurate documentation and training staff, QMS helps pharma companies achieve regulatory compliance and deliver safe, high-quality products consistently.

Read More »
CQA

Critical Quality Attribute (CQA) in 2026: Expert Guide to Ensure Drug Quality

Critical Quality Attributes (CQAs) are crucial in pharmaceutical manufacturing because they directly affect drug safety, efficacy, and consistency. Regulatory agencies including the FDA and ICH require thorough CQA assessment to minimize risks and ensure high-quality medicines. By following best practices like early identification, risk assessment, and continuous monitoring, manufacturers can maintain robust production processes. Implementing modern strategies such as Quality by Design and integrating CQAs with quality assurance systems ensures compliance and safeguards patient health throughout the product lifecycle

Read More »

Out of Specification (OOS) in pharma Industry: Complete Investigation Guide & Prevention in 2026

Out of Specification (OOS) events represent a crucial quality challenge in pharmaceuticals, impacting product safety and regulatory compliance. Occurring in 2.3% of samples in 2026, these events demand thorough investigations and corrective actions. This blog explores the causes, investigation steps, and prevention strategies to help pharmaceutical companies strengthen their quality systems and maintain trust in their products.

Read More »